MET Signaling Pathway: A Rational Target for Cancer Therapy

被引:97
作者
Appleman, Leonard J. [1 ]
机构
[1] Univ Pittsburgh Canc Inst, Pittsburgh, PA USA
关键词
ACQUIRED-RESISTANCE; MUTATIONS; TUMORS; INHIBITORS; GEFITINIB; GROWTH; GENE;
D O I
10.1200/JCO.2011.37.7929
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
[No abstract available]
引用
收藏
页码:4837 / 4838
页数:2
相关论文
共 14 条
[1]
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib [J].
Bean, James ;
Brennan, Cameron ;
Shih, Jin-Yuan ;
Riely, Gregory ;
Viale, Agnes ;
Wang, Lu ;
Chitale, Dhananjay ;
Motoi, Noriko ;
Szoke, Janos ;
Broderick, Stephen ;
Balak, Marissa ;
Chang, Wen-Cheng ;
Yu, Chong-Jen ;
Gazdar, Adi ;
Pass, Harvey ;
Rusch, Valerie ;
Gerald, William ;
Huang, Shiu-Feng ;
Yang, Pan-Chyr ;
Miller, Vincent ;
Ladany, Marc ;
Yang, Chih-Hsin ;
Pao, William .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20932-20937
[2]
Opinion -: Invasive growth:: a MET-driven genetic programme for cancer and stem cells [J].
Boccaccio, Carla ;
Comoglio, Paolo M. .
NATURE REVIEWS CANCER, 2006, 6 (08) :637-645
[3]
MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors [J].
Cepero, Virna ;
Sierra, J. Rafael ;
Corso, Simona ;
Ghiso, Elena ;
Casorzo, Laura ;
Perera, Tim ;
Comoglio, Paolo Maria ;
Giordano, Silvia .
CANCER RESEARCH, 2010, 70 (19) :7580-7590
[4]
MOLECULAR-CLONING OF A NEW TRANSFORMING GENE FROM A CHEMICALLY TRANSFORMED HUMAN CELL-LINE [J].
COOPER, CS ;
PARK, M ;
BLAIR, DG ;
TAINSKY, MA ;
HUEBNER, K ;
CROCE, CM ;
VANDEWOUDE, GF .
NATURE, 1984, 311 (5981) :29-33
[5]
Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863
[6]
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling [J].
Engelman, Jeffrey A. ;
Zejnullahu, Kreshnik ;
Mitsudomi, Tetsuya ;
Song, Youngchul ;
Hyland, Courtney ;
Park, Joon Oh ;
Lindeman, Neal ;
Gale, Christopher-Michael ;
Zhao, Xiaojun ;
Christensen, James ;
Kosaka, Takayuki ;
Holmes, Alison J. ;
Rogers, Andrew M. ;
Cappuzzo, Federico ;
Mok, Tony ;
Lee, Charles ;
Johnson, Bruce E. ;
Cantley, Lewis C. ;
Janne, Pasi A. .
SCIENCE, 2007, 316 (5827) :1039-1043
[7]
Gordon M., 2011, J CLIN ONCOL S, V29, p196s
[8]
Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102, a Fully Human Hepatocyte Growth Factor-Neutralizing Monoclonal Antibody, in a First-in-Human Study of Patients with Advanced Solid Tumors [J].
Gordon, Michael S. ;
Sweeney, Christopher J. ;
Mendelson, David S. ;
Eckhardt, S. Gail ;
Anderson, Abraham ;
Beaupre, Darrin M. ;
Branstetter, Daniel ;
Burgess, Teresa L. ;
Coxon, Angela ;
Deng, Hongjie ;
Kaplan-Lefko, Paula ;
Leitch, Ian M. ;
Oliner, Kelly S. ;
Yan, Lucy ;
Zhu, Min ;
Gore, Lia .
CLINICAL CANCER RESEARCH, 2010, 16 (02) :699-710
[9]
Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer [J].
Graziano, Francesco ;
Galluccio, Nadia ;
Lorenzini, Paola ;
Ruzzo, Annamaria ;
Canestrari, Emanuele ;
D'Emidio, Silvia ;
Catalano, Vincenzo ;
Sisti, Valerio ;
Ligorio, Claudia ;
Andreoni, Francesca ;
Rulli, Eliana ;
Di Oto, Enrico ;
Fiorentini, Giammaria ;
Zingaretti, Costantino ;
De Nictolis, Michele ;
Cappuzzo, Federico ;
Magnani, Mauro .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (36) :4789-4795
[10]
MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib [J].
Lennerz, Jochen K. ;
Kwak, Eunice L. ;
Ackerman, Allison ;
Michael, Michael ;
Fox, Stephen B. ;
Bergethon, Kristin ;
Lauwers, Gregory Y. ;
Christensen, James G. ;
Wilner, Keith D. ;
Haber, Daniel A. ;
Salgia, Ravi ;
Bang, Yung-Jue ;
Clark, Jeffrey W. ;
Solomon, Benjamin J. ;
Iafrate, A. John .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (36) :4803-4810